Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy.

MLA

Griffiths, R. I., et al. “Medical Resource Use and Costs among Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drug Therapy.” Arthritis Care and Research : The Official Journal of the Arthritis Health Professions Association, vol. 13, no. 4, Aug. 2000, pp. 213–26. EBSCOhost, https://doi.org/10.1002/1529-0131(200008)13:4<213::aid-anr6>3.0.co;2-2.

APA

Griffiths, R. I., Bar-Din, M., MacLean, C. H., Sullivan, E. M., Herbert, R. J., & Yelin, E. H. (2000). Medical resource use and costs among rheumatoid arthritis patients receiving disease-modifying antirheumatic drug therapy. Arthritis Care and Research : The Official Journal of the Arthritis Health Professions Association, 13(4), 213–226. https://doi.org/10.1002/1529-0131(200008)13:4<213::aid-anr6>3.0.co;2-2

Chicago

Griffiths, R I, M Bar-Din, C H MacLean, E M Sullivan, R J Herbert, and E H Yelin. 2000. “Medical Resource Use and Costs among Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drug Therapy.” Arthritis Care and Research : The Official Journal of the Arthritis Health Professions Association 13 (4): 213–26. doi:10.1002/1529-0131(200008)13:4<213::aid-anr6>3.0.co;2-2.